Suppr超能文献

新型5-羟色胺3(血清素-3)受体拮抗剂,II. 嘧啶并[1,6-a]吲哚的合成与构效关系

New 5-HT3 (serotonin-3) receptor antagonists, II. Synthesis and structure-activity relationships of pyrimido[1,6-a]indoles.

作者信息

Kato M, Nishino S, Ito K, Yamakuni H, Takasugi H

机构信息

New Drug Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan.

出版信息

Chem Pharm Bull (Tokyo). 1994 Dec;42(12):2556-64. doi: 10.1248/cpb.42.2556.

Abstract

A series of pyrimido[1,6-alpha]indol-1(2H)-ones was prepared and evaluated for 5-HT3 receptor antagonist activity. The compounds in this series were regarded as bioisosters of the pyrido[1,2-alpha]indol-6(7H)-ones previously reported. High potency was found for compounds having 5-methyl substituents on both the pyrimido[1,6-alpha]indole ring and the imidazole ring. Optimized members of this series, 8b and (+)-26a, were potent 5-HT3 receptor antagonists as determined by measuring inhibition of the Bezold-Jarisch reflex in anesthetized rats (ED50 0.6 and 0.8 microgram/kg i.v., respectively), being equipotent to or more potent than FK 1052 (1) in the previous paper and 20- to 30-fold more potent than ondansetron (2).

摘要

合成了一系列嘧啶并[1,6-α]吲哚-1(2H)-酮,并对其5-羟色胺3(5-HT3)受体拮抗剂活性进行了评估。该系列化合物被视为先前报道的吡啶并[1,2-α]吲哚-6(7H)-酮的生物电子等排体。发现嘧啶并[1,6-α]吲哚环和咪唑环上均具有5-甲基取代基的化合物具有高效力。通过测量麻醉大鼠的贝佐尔德-雅里什反射抑制作用确定,该系列的优化成员8b和(+)-26a是强效5-HT3受体拮抗剂(ED50分别为0.6和0.8微克/千克静脉注射),与前文的FK 1052(1)效力相当或更强,且比昂丹司琼(2)强20至30倍。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验